{"id":4992,"date":"2026-10-26T08:13:43","date_gmt":"2026-10-26T04:13:43","guid":{"rendered":"https:\/\/silkaesthetic.ge\/?p=4992"},"modified":"2026-10-26T15:52:39","modified_gmt":"2026-10-26T11:52:39","slug":"vascular-technology","status":"publish","type":"post","link":"https:\/\/silkaesthetic.ge\/en\/vascular-technology\/","title":{"rendered":"How are lasers used for visible blood vessels?"},"content":{"rendered":"<p><\/p>\n<article lang=\"en\">\n<figure class=\"blog-topic-cover\" style=\"margin:0 0 1.5rem;\">\n<img src=\"https:\/\/silkaesthetic.ge\/wp-content\/uploads\/2026\/10\/vascular-technology.png\" alt=\"Conceptual 3D diagram of a visible vessel within the dermis and its light target.\" style=\"display:block;width:100%;height:auto;object-fit:contain;\" decoding=\"async\"><figcaption>The diagram explains selective-vessel targeting, not a promise to cure rosacea or remove every blood vessel.<\/figcaption><\/figure>\n<p class=\"review-date\">Sources reviewed: 25 October 2026.<\/p>\n<p class=\"read-time\">Reading time: 2 min.<\/p>\n<h2>What does the light target?<\/h2>\n<p>Haemoglobin in blood is an important light target when treating visible facial vessels. EADV describes heat generation in selected vessels by lasers and IPL. Seeing one colour on the skin does not establish that the same device suits every lesion.<\/p>\n<p class=\"sources\">Source: <a href=\"https:\/\/eadv.org\/wp-content\/uploads\/2023\/04\/EADV-Laserevidence-based-devices_1-Facial-Telengiectasias.pdf\" rel=\"noopener noreferrer\">EADV: Facial telangiectasia laser and light procedures<\/a><\/p>\n<h2>Which technologies does a clinical guideline discuss?<\/h2>\n<p>The British Association of Dermatologists\u2019 rosacea guideline considers pulsed dye laser, Nd:YAG or IPL for persistent facial redness. These are options for individual assessment, not identical choices for every patient. IPL is not a laser, although it may be used for the same concern.<\/p>\n<p class=\"sources\">Source: <a href=\"https:\/\/academic.oup.com\/bjd\/article\/185\/4\/725\/6599936\" rel=\"noopener noreferrer\">British Association of Dermatologists rosacea guideline, 2021<\/a><\/p>\n<h2>Does reducing a vessel mean curing rosacea?<\/h2>\n<p>NIH patient information notes that laser treatment addresses rosacea\u2019s symptoms, not its causes. Visible improvement therefore does not resolve every aspect of disease management. Discuss treatment goals and ongoing care with a doctor instead of calling a change in redness a complete cure.<\/p>\n<p class=\"sources\">Source: <a href=\"https:\/\/newsinhealth.nih.gov\/sites\/newsinhealth\/files\/2020\/July\/NIHNiHJul2020.pdf\" rel=\"noopener noreferrer\">NIH: Relieving rosacea<\/a><\/p>\n<h2>What safety matters should be discussed?<\/h2>\n<p>EADV describes temporary swelling and possible pigment changes; eye protection is essential.<\/p>\n<p class=\"sources\">Source: <a href=\"https:\/\/eadv.org\/wp-content\/uploads\/2023\/04\/EADV-Laserevidence-based-devices_1-Facial-Telengiectasias.pdf\" rel=\"noopener noreferrer\">EADV: Facial telangiectasia laser and light procedures<\/a><\/p>\n<h2>How do we distinguish general redness from a specific target?<\/h2>\n<p>Describe what you notice and what concerns you, but do not select your own diagnosis from a photograph. Ask the doctor what has been assessed and why a particular light source is being considered. An article on small facial vessels should not automatically be extended to every leg-vein problem. Clarifying the condition comes before choosing the device.<\/p>\n<h2>What should an outcome promise specify?<\/h2>\n<p>A clear explanation distinguishes assessment of visible vessels, diffuse redness and personal discomfort. Ask what the practitioner considers success and how it will be checked. \u201cRemoves vessels\u201d does not describe potential limitations. The photographs and research accompanying an offer should concern the same problem you are discussing.<\/p>\n<aside class=\"educational-note\">Educational information, not a substitute for an individual medical assessment. The exact device\u2019s intended use, safety and local requirements need separate verification.<\/aside>\n<\/article>\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Vascular lasers and IPL, haemoglobin, the limits of rosacea management and safety considerations.<\/p>\n","protected":false},"author":1,"featured_media":4872,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4992","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/silkaesthetic.ge\/en\/wp-json\/wp\/v2\/posts\/4992","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/silkaesthetic.ge\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/silkaesthetic.ge\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/silkaesthetic.ge\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/silkaesthetic.ge\/en\/wp-json\/wp\/v2\/comments?post=4992"}],"version-history":[{"count":1,"href":"https:\/\/silkaesthetic.ge\/en\/wp-json\/wp\/v2\/posts\/4992\/revisions"}],"predecessor-version":[{"id":4993,"href":"https:\/\/silkaesthetic.ge\/en\/wp-json\/wp\/v2\/posts\/4992\/revisions\/4993"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/silkaesthetic.ge\/en\/wp-json\/wp\/v2\/media\/4872"}],"wp:attachment":[{"href":"https:\/\/silkaesthetic.ge\/en\/wp-json\/wp\/v2\/media?parent=4992"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/silkaesthetic.ge\/en\/wp-json\/wp\/v2\/categories?post=4992"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/silkaesthetic.ge\/en\/wp-json\/wp\/v2\/tags?post=4992"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}